The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1587
ISSUE1587
December 16, 2019
Trifarotene (Aklief) - A New Topical Retinoid for Acne
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Trifarotene (Aklief) - A New Topical Retinoid for Acne
December 16, 2019 (Issue: 1587)
The FDA has approved trifarotene 0.005% cream
(Aklief – Galderma) for topical treatment of acne
vulgaris in patients ≥9 years old. Trifarotene is the
fourth topical retinoid to be approved in the US for
treatment of acne; tretinoin (Retin-A,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.